VipStockReports

Penny Stock Buzzers - MediSwipe Inc (OTCMKTS:MWIP), Affymax, Inc.(OTCMKTS:AFFY), CodeSmart Holdings Inc(OTCBB:ITEN), Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY)

 
Repost This

Middletown, DE -- (SBWIRE) -- 09/03/2013 -- VipStockReports.com screens the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way. Today our focus is on: MediSwipe Inc (OTCMKTS:MWIP), Affymax, Inc.(OTCMKTS:AFFY), CodeSmart Holdings Inc(OTCBB:ITEN), Roche Holding Ltd. (ADR)(OTCMKTS:RHHBY)

MediSwipe Inc(OTCMKTS:MWIP) opened the session at $0.05, remained amid the day range of $0.05 - $0.06, and closed the session at $0.0565. The stock showed a positive performance of +18.45% in previous trading session. The stock gained a volume of 20.37 million shares and the average volume of the stock remained 1.94 million shares. MediSwipe, Inc. provides patient solutions for electronically processing transactions within the healthcare industry in the United States. It offers terminal-based service packages and integrated Web Portal add-ons that include digital patient records, and accounts receivable financing for physicians, and medical dispensaries.

Why Should Investors Buy MWIP After The Recent Gain? Just Go Here and Find Out

Affymax, Inc. (OTCMKTS:AFFY) traded with volume of 1.26 million shares in the prior session and the average volume of the stock remained 1.44 million shares. The 52 week range of the stock remained $0.78 - $27.74. The stock showed a negative movement of -8.77% and closed its session at $1.56. The market capitalization of the stock remained 58.48 million. Affymax, Inc., a biopharmaceutical company, engages in discovering, developing, and delivering therapies that improve the lives of patients with kidney diseases, and other serious and life-threatening illnesses. It offers OMONTYS (peginesatide) injection for the treatment of anemia due to chronic kidney disease in adult patients on dialysis.

Why Should Investors Buy AFFY After the Recent Fall? Just Go Here and Find Out

CodeSmart Holdings Inc (OTCBB:ITEN) exchanged 458,583.00 shares and the average volume remained 134,305.00 shares. The stock escalated +17.65% and closed the session at $4.60. The shares outstanding of the stock remained 15.80 million. CodeSmart Holdings, Inc. focuses on providing on-line education services for medical coding and billing to healthcare professionals in the United States. It offers CODESMART UNIVERSITY, an on-line training program that teaches current and new medical coding professionals on ICD-10-CM/PCS coding systems.

For How Long ITEN will fight for Profitability? Read This Trend Analysis report

Roche Holding Ltd. (ADR) (OTCMKTS:RHHBY) gained volume of 467,289.00 shares, while the average volume remained 496,095.00 shares. The stock decreased -1.16% and finished the session Friday at $62.26. The EPS of the stock remained 3.50. The one month of the stock was +1.32% and three month trend remained negative -0.13%. Roche Holding AG operates in the pharmaceuticals and diagnostics businesses in Switzerland, European Union, and internationally. It discovers, develops, and delivers diagnostic and therapeutic products and services that enable patients and healthcare professionals in the detection, and treatment monitoring of diseases.

Has RHHBY Found The Bottom and Ready To Move Up? Find Out Here

About VipStockReports.com:
We screen the markets looking for Hot Emerging Micro-cap and Small cap stocks that look to Run High. Once we find the 'Next Hot Penny Stock' with Monster Upside Potential we immediately Email it to you in our detailed VIP Report so you can Beat Rest of the Crowd!!

Our team STRONGLY believes the penny stock market can powerfully reward average traders, and we are here to lead the way.

Disclaimer:
VipstockReports.com newsletters and website: The disclaimer is to be read entirely and fully understood before using our website, or joining our newsletter email list. Never invest into a stock discussed on this website or the Vipstockalerts.com newsletter unless you can afford to lose your entire investment. Please consult with a certified financial advisor before making any investment decisions.

VipStockReports.com and any affiliates and information providers make no implied or express warranties on the information provided. Please verify quotes with your financial advisor before making investment decisions. This is not to be construed as a solicitation to buy or sell securities. As with any stock, the featured companies profiled on the VipstockReports.com web site and/or newsletter involve a high degree of volatility and risk, and all investors should know that they may lose a portion of or all of their investment if they decide to purchase any stocks.

Read Full Disclaimer at: http://www.vipstockreports.com/disclaimer/